These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25479065)

  • 1. Low vitamin D level and impact on severity and recurrence of Clostridium difficile infections.
    Abdelfatah M; Nayfe R; Moftakhar B; Nijim A; El Zoghbi M; Donskey CJ; Kandil H; Watkins RR
    J Investig Med; 2015 Jan; 63(1):17-21. PubMed ID: 25479065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status and severity of Clostridium difficile infections: a prospective cohort study in hospitalized adults.
    van der Wilden GM; Fagenholz PJ; Velmahos GC; Quraishi SA; Schipper IB; Camargo CA
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):465-70. PubMed ID: 24408036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients.
    Abdelfatah M; Nayfe R; Nijim A; Enriquez K; Ali E; Watkins RR; Kandil H
    J Investig Med; 2015 Jun; 63(5):747-51. PubMed ID: 25871748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Clostridium difficile Infection May Be Associated With Vitamin D Deficiency.
    Wong KK; Lee R; Watkins RR; Haller N
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):682-7. PubMed ID: 25623479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection.
    Stewart DB; Berg AS; Hegarty JP
    Ann Surg; 2014 Aug; 260(2):299-304. PubMed ID: 24374512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Clostridium difficile infection is associated with increased mortality.
    Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
    Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in serum albumin and total protein in patients with hospital-acquired Clostridium difficile infection.
    Kumarappa VS; Patel H; Shah A; Baddoura W; DeBari VA
    Ann Clin Lab Sci; 2014; 44(1):32-7. PubMed ID: 24695471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and impact of Clostridium difficile recurrence on haematology patients.
    Scappaticci GB; Perissinotti AJ; Nagel JL; Bixby DL; Marini BL
    J Antimicrob Chemother; 2017 May; 72(5):1488-1495. PubMed ID: 28186243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Clostridium difficile infection in intensive care unit patients.
    Jasiak NM; Alaniz C; Rao K; Veltman K; Nagel JL
    Am J Infect Control; 2016 Jan; 44(1):36-40. PubMed ID: 26432184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
    Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
    Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a recurrent Clostridium difficile risk-prediction model.
    Zilberberg MD; Reske K; Olsen M; Yan Y; Dubberke ER
    J Hosp Med; 2014 Jul; 9(7):418-23. PubMed ID: 24700708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of Health Services Among Adults With Recurrent Clostridium difficile Infection: A 12-Year Population-Based Study.
    Kuntz JL; Baker JM; Kipnis P; Li SX; Liu V; Xie Y; Marcella S; Escobar GJ
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):45-52. PubMed ID: 27760583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
    Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
    J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.